Supplementary Table S1 from Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model

Autor:	Nicholas Chiorazzi, Kanti R. Rai, Jonathan A. Pachter, David T. Weaver, Sujata Sharma, Marisa Peluso, Jeffery L. Kutok, Sheila Waters, Yasmine Kieso, Michael Ibrahim, Priyadarshini Ravichandran, Yu-Ju Chen, Morgan King-Richards, Gerardo Ferrer, Jacqueline C. Barrientos, Shih-Shih Chen
Rok vydání:	2023
Popis:	IC50 values of PI3K isoform inhibitors used. Duvelisib5, IPI-3063 (PI3K-d inhibitor)5, IPI-549 (PI3K-g inhibitor used in vitro)50, IPI-5243 (PI3K-g inhibitor used in vivo).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ead5388474787e49d884681dd3bc434 https://doi.org/10.1158/1078-0432.22652506 Zobrazit plný text záznamu